Introduction
============

Oman is situated in the South East of the Arabian Peninsula along the East coast of the Arabian Gulf ( [Figure 1](#f1){ref-type="fig"}). It has its borders with United Arab Emirates to the North, Saudi Arabia to the West and Yemen to the South West. Oman is the second largest territory in the Arabian Peninsula with an area of 82,000 square miles and a coastline length of 1,300 miles. The native Omani population comprises around 2.2 million inhabitants, and the rate of annual population increase is approximately 25 per 1000. Oman has a young population with nearly half of the population being under 15 years. The Omani population is characterized by a high growth rate, large family size, consanguineous marriages, and the presence of genetic isolates.

![Oman is situated in the South East of the Arabian Peninsula along the East coast of the Arabian Gulf.](f1000research-4-7471-g0000){#f1}

Clinical genetic services were introduced in the Sultanate of Oman in the past decade and they have become an important component of health care. This greatly facilitated the systematic collection of data on genetic diseases and birth defects in the past few decades. With the inauguration of the National Genetic Center in 2013, the existing clinical genetic services were supplemented by sophisticated genetic laboratory services.

The amount of published data available on genetic disorders in the Sultanate is considerable. There were a few previous attempts to list the genetic diseases reported in Oman ^[@ref-1]--\ [@ref-4]^ and to link them to specific population groups and geographic locations ^[@ref-5],\ [@ref-6]^, analyze population structure ^[@ref-7]^, and to estimate the impact of genetic disorders and birth defects on the community ^[@ref-4]^ and summarize the genetic services available ^[@ref-8]^. The advances in bioinformatics required to annotate human genomic variants and to place them in public data repositories have not kept pace with their discovery. The deposition of such data in the public domain is essential to maximize both their scientific and clinical utility ^[@ref-9]^.

Hence, in the current study we present a comprehensive compilation of germline mutations in nuclear genes associated with human disease in the Omani population.

Materials and methods
=====================

The wealth of genetic variant data in Omani nationals was collected from multiple sources which form a basis for research into genetic conditions reported from Oman. Multiple sources of data were reviewed to form repository of mutations in Omani nationals introduced in this paper. The sources of data included:

\(1\) 1993--2015 records of patients consulted by clinical geneticists of the Royal Hospital, the largest tertiary hospital in Oman;

\(2\) 2008--2015 publications curated from PUBMED on birth defects and genetic conditions in Omani nationals. The keywords used were: "Oman", "Genetic disorders", "Birth defects", "mutations";

\(3\) 2012--2014 commercial laboratories referral registry at the Royal Hospital for the samples tested overseas.

\(4\) The internal genetic variant repository of the National Genetic Center \<\< <HTTP://ogvd.net>\>\>;

The data presented in this article was manually curated. The OMIM identifiers, Phenotype MIM accession numbers, Phenotype name (OMIM), mutation descriptions, and relevant publications with PMID numbers were all collected from the NCBI database repository. All unavailable through PubMed mutation details were checked with ClinVar, LOVD and CentoMD. The details of unpublished mutations are not included in the present study and feature in [Table 2](#T2){ref-type="table"} as "Novel mutations".

Results
=======

In this study, a wide range of genetic conditions with known mutations collected in Omani nationals were analysed. The disease classifications are comprised of 44 gene variants causing neurodevelopmental disorders, 21 inborn errors of metabolism, 13 endocrinopathies, 15 skeletal dysplasias, nine disorders of the immune system, four hereditary blood disorders as well as other National groups ( [Table 1](#T1){ref-type="table"}).

###### Range of genetic conditions with known mutations in Omani nationals (details presented in [Table 2](#T2){ref-type="table"} and [Table 3](#T3){ref-type="table"}).

  ---------------------------------------------------------------------------------------------------------------
  Range of Genetic Conditions with\                  Number\         Number\       Novel\          Novel genes\
  known mutations in Omani nationals                 of disease\     of disease\   Mutations of\   and novel\
                                                     causing genes   causing\      known genes     genetic\
                                                                     mutations                     mechanisms
  -------------------------------------------------- --------------- ------------- --------------- --------------
                Beta-Globin                          1               33            2               3

                Alpha-Globin                         2               22            3               2

                Delta-Globin                         1               14            3               0

  Other hemolytic and hemorrhagic disorders          3               5             3               2

  Neurodevelopmental disorders                                                                     

           Conditions with intellectual disability   20              23            9               7

  Primary Microcephaly                               5               5             2               2

  Epileptic syndromes                                2               2             0               1

  Neurodegenerative conditions                       6               7             1               1

  Syndromic ciliopathies                             6               7             5               3

  Hereditary spastic paraplegias                     5               6             4               3

  Neuropathies and neuromuscular\                    8               13            1               1
  disorders                                                                                        

  Arthrogryposis                                     3               3             2               2

  Inborn errors of metabolism                        21              28            21              2

  Endocrine disorders                                13              28            2               5

  Intrahepatic cholestasis and gut anomalies         4               8             3               0

  Disorders of the immune system                     9               15            3               4

  Familial cancers                                   4               6             1               0

  Skeletal dysplasias and osteodysplasias            15              23            6               8

  Cardiogenetic conditions                           2               2             1               1

  Renal disorders and dysplasias                     6               13            0               1

  Skin, nails, and hair disorders                    6               10            0               3

  Cutis laxa syndromes                               2               7             0               3

  Ophthalmological diseases including\               5               8             0               2
  blindness                                                                                        

  Congenital deafness                                1               3             0               1

  Congenital lipodystrophies                         5               5             0               1

  Cystic fibrosis                                    1               4             1               2

  **Total**                                          **156**         **300**       **83**          **58**
  ---------------------------------------------------------------------------------------------------------------

Extensive genetic studies were performed in Oman for Genetic Blood Disorders and various conditions leading to intellectual disabilities, mental and physical handicap.

In total more than 150 rare genetic disorders were listed in [Table 2](#T2){ref-type="table"} and [Table 3](#T3){ref-type="table"} with relevant OMIM numbers, PubMed ID (PMID), Gene/Locus name, nucleotide(s) change(s) and the source of the data (PubMed ID Number/ OMIM/ClinVar/LOVD/CentoMD). The names of genetic conditions in [Table 2](#T2){ref-type="table"} are stated as found in OMIM "Phenotype-Gene Relationships" table as "Phenotype" arranged in alphabetical order. In [Table 3](#T3){ref-type="table"}, we present a separate list of 69 known mutations (11--15) that were collected through service provision at the Hemoglobinopathy Laboratory at the National Genetic Center in Oman.

###### List of disease-associated mutations in Omani nationals.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------
  No.                      Phenotype (OMIM)                            OMIM            PMIM ID       Gene/Locus    Nucleotide change          Source:\
                                                                                                                                              Pubmed ID Nos/\
                                                                                                                                              Registration at\
                                                                                                                                              international\
                                                                                                                                              databases
  ------------------------ ------------------------------------------- --------------- ------------- ------------- -------------------------- ------------------
  1                        Achondroplasia                              100800          134934        FGFR3         c.749G\>C;                 LOVD

  c.1172C\>A                                                                                                                                  

  2                        Adrenal hyperplasia, congenital, due\       201910          613815        CYP 21A2      p.I236N                    21274396
                           to 21-hydroxylase deficiency                                                                                       

  p.V237E                                                                                                                                     

  p.M239K                                                                                                                                     

  c\. 306T insert,                                                                                                                            

  p.Q318X; conv Cyp 21P\                                                                                                                      
  to Cyp 21A2                                                                                                                                 

  3                        Adrenal hyperplasia, congenital, due\       202110          609300        CYP17A1       c.287G\>A\                 24498484
                           to 17-hydroxylase deficiency                                                            p.Arg96Gln                 

  4                        Allopecia universalis congenita             \*203655        602302        HR            c\. 2776+1, G\>A           9736769

  c.1022T\>A                                                                                                                                  

  5                        Alport syndrome, autosomal dominant         104199          104200        COL4A3        c.479G\>A;                 14871398

  c.232delG                                                                                                                                   

  6                        Alport syndrome, autosomal recessive        203780          120070        COL4A3        R1215X(CGA\>TG             14582039

  7                        Alport syndrome, X-linked (ATS)             301050          303630        COL 4A5       del exons 7--8 and\        25333070\
                                                                                                                   31--36                     15149316

  potential duplication\                                                                                                                      
  of exons 21 -- 30+/-\                                                                                                                       
  exon 20                                                                                                                                     

  8                        Alstrom syndrome                            \*606884        203800        ALMS1         Novel mutation             17594715

  9                        Amelogenesis imperfecta, type IIA3          \*613211        613214        WDR72         c.978T-to-ter              19853237

  (V968X);                                                                                                                                    

  2857delA                                                                                                                                    

  10                       Apparent Mineralocorticoid\                 \*218030        614232        HSD11B2       Exon 1: R74G ;             15134813
                           excess (AME 1);Cortisol 11-beta-\                                                                                  
                           ketoreductase deficiency                                                                                           

  Pdelta1nt                                                                                                                                   

  (P75Delta1nt)                                                                                                                               

  Exon2: L114Delta6nt                                                                                                                         

  Exon 5: V322ins9nt                                                                                                                          

  Exon 3 :A221V                                                                                                                               

  11                       Arterial tortuosity syndrome                208050          208050        SLC2A10       243C-G                     16550171

  12                       Arthrogryposis, renal dysfunction, and\     \*608552        208085        Vps33B        c.350delC                  15052268
                           cholestasis 1                                                                                                      

  13                       Autoimmune Lymphoproliferative\             601859          601853        FAS           c.232 del G, exon3         8787672
                           Syndrome (Type A)                                                                                                  

  14                       Bardet-Biedl Syndrome 9 (BBS9)              \*615986        615986        PTHB1         IVS 17/IGTA variant        17106446

  15                       Bardet-Biedl Syndrome 10 (BBS10)            \*209900        209900        FLJ23560      n.364fsX368                17106446

  FLJ 23560                                                                                                                                   

  16                       Brain Calcifications/Coat's like\           \*613658        613658        NA            Linkage to 2q36.3          19161147
                           syndrome/Rajab syndrome                                                                                            

  17                       Breast cancer                               114480          114480        BRCA 1        2080insA                   18340530

  18                       Carbamoylphosphate synthetase I\            \*238970        237300        CPSI          c.1590dupT                 22106832
                           deficiency                                                                                                         

  19                       Carnitinepalmitoyl carboxylase\             \*600650        1p32.3        CPT2 gene     detectable mutations\      ClinVar
                           deficiency                                                                              were excluded              

  20                       Central hypoventilation syndrome,\          603851          209880        PHOX2B        5 Alanine Expansions       ClinVar
                           congenital                                                                                                         

  10 Alanine expansions                                                                                                                       

  21                       Ceroid lipofuscinosis, neuronal,\           \*204500        607998        TPP1          positive linkage           17690061
                           2 (CLN2)                                                                                                           

  22                       Charcot-Marie-Tooth disease, type 4A        214400          214400        GDAP1         Start-codon mutation       22200116

  23                       Cohen Syndrome (COH 1)                      \*216550        216550        VPS13B        7934G\>A                   15173253

  24                       Cystic Fibrosis                             \*219700        7q31.2        CFTR          102T\>A+S549R(T\>G)\]      25829996;\
                                                                                                                                              10480369

  delta F508                                                                                                                                  

  F208Del;                                                                                                                                    

  S549Rdel                                                                                                                                    

  25                       Cholestasis intrahepatic                    \*243300        243300        ATP8B1        (exon 15) het del          CentoMD;\
                                                                                                                                              15239083

  26                       Cholestasis, benign recurrent\              605479          605479        ABCB11        c.149G.A                   LOVD;\
                           intrahepatic, 2                                                                                                    CentoMD

  c.1416T.A                                                                                                                                   

  27                       Cholestasis, progressive familial\          602347          602347        ABCB4         c.2800G\>A                 LOVD
                           intrahepatic 3                                                                                                     

  28                       Cholestasis, intrahepatic, of\              147480          147480        ATP8B1        c.1286A\>C;                LOVD;\
                           pregnancy, 1                                                                                                       CentoMD

  Novel mutation                                                                                                                              

  Novel mutation                                                                                                                              

  29                       Chondrodysplasia, Grebe type (Grebe\        \*200700        200700        GDF5          Del G1144;                 16636240
                           Acromesomelic Dysplasia)                                                                                           

  Transition A1137G                                                                                                                           

  30                       Chronic granulomatous disease due\          \*233700        233700        NCF1          c.579G\>A                  24446915;\
                           to deficiency of NCF1                                                                                              24446915

  Novel mutation                                                                                                                              

  31                       Chronic Granulomatous Disease,\             \*306400        306400        CYBB, XK      Del gp91-phox gene\        24446915
                           X-Linked                                                                                (CYBB)                     

  del McLeod gene (XK)                                                                                                                        

  32                       Crigler-Naj ar Syndrome, type II            606785          606785        UGT1A1        c.211G\>A                  9630669

  c.1456T\>G                                                                                                                                  

  33                       Cutis laxa, autosomal recessive,\           \*219200        219200        ATP6V0A2      c.294+1G4A                 18157129
                           type IIA (with congenital defect of\                                                                               
                           glycosulation)                                                                                                     

  c.1929delA                                                                                                                                  

  34                       Cutis laxa, autosomal recessive,\           \*614438        614438        PYCR1         356G\>A                    19648921
                           type IIIB                                                                                                          

  566C\>T                                                                                                                                     

  356G4A                                                                                                                                      

  c.356G\>A                                                                                                                                   

  c.566C\>T                                                                                                                                   

  35                       Deafness, autosomal recessive 1A            \*220290        2220290       GJB2          S86T                       11748849

  35delG                                                                                                                                      

  167delT                                                                                                                                     

  36                       Diabetes mellitus, permanent neonatal       606176          606176        ABCC8         c.4480C\>T                 9769320

  37                       Dushenne Muscular Dystrophy                 320200          320200        DMD           Del exon 7                 19449031

  Dupl exons 55 to 77                                                                                                                         

  c.4996C\>T                                                                                                                                  

  c.1733_1734delTA                                                                                                                            

  c.1175T \> G                                                                                                                                

  c.1647T\>G;                                                                                                                                 

  c.1521_1523delCTT                                                                                                                           

  38                       Epiphyseal dysplasia, macrocephaly,\        \*226900        NA            15q26         Linkage D15S205/\          11389160
                           variable CC agenesis, spindle-shaped\                                                   D15S966                    
                           fingers, mental retardation                                                                                        

  39                       Ectodermal dysplasia 1, hypohidrotic,\      305100          305100        ED1           c.G1113A;\                 11279189
                           X-linked (EDA)                                                                          Gly291Arg                  

  40                       Ectodermal dysplasia 10B,\                  224900          224900        EDAR          718delAAA                  20979233
                           hypohidrotic/hair/tooth type,\                                                                                     
                           autosomal recessive                                                                                                

  41                       Enhanced S-cone syndrome (Golden-\          \*268100        268100        NR2E3         c.1117 A\>G                24891813
                           Favre syndrome)                                                                                                    

  42                       Ellis Van-Creveld                           \*225500        225500        EVC           Frameshift in exon 13      17024374;\
                                                                                                                                              20184732

  Novel mutation                                                                                                                              

  43                       Epilepsy, progressive myoclonic 2B\         254780          254780        NHLRC1        c.468_469delAG             18263761
                           (MELF)                                                                                                             

  44                       Escobar syndrome                            \*265000        265000        CHRNG         γ78dup(3)                  16826520

  45                       Ethyl Malonic Aciduria                      608451          608451        ETHE1         c.487C\>T                  Cento MD;\
                                                                                                                                              14732903

  46                       Factor X deficiency/Familiar CRM            \*227600        227600        F10           c.381G\>A                  12574802

  47                       Fanconi anemia, complementation\            605724          605724        BRCA2         9609C\>T                   22660720
                           group D1 (FAD1)                                                                                                    

  exon 25                                                                                                                                     

  48                       Fanconi-Bickel Syndrome (GLUT2)             138160          227810        SLC2A2        c.1259G\>T;                22660720

  c.1127T\>G                                                                                                                                  

  49                       Familial Mediterranean fever, AR            \*608107        247100        MEFV          c.442G\>C                  CentoMD,\
                                                                                                                                              ClinVar

  50                       Favism                                      305900          134700        G6PD          c.335A\>T                  8860013

  G6PD Chatham                                                                                                                                

  G6PD A-                                                                                                                                     

  2 novel mutations                                                                                                                           

  51                       Gastrointestinal defects and\               243150          243150        TTC7A         Q712X                      25534311
                           immunodeficiency syndrome                                                                                          

  52                       Geroderma Osteodysplastica\                 \*231070        231070        SCYL1BP1      C-1_1 :GA\>CT;             18997784
                           Hereditaria                                                                                                        

  257delC                                                                                                                                     

  53                       Geroderma osteodysplastica\                 \*231070        231070        GORAB         367G-T                     19648921
                           Hereditatria                                                                                                       

  54                       Glaucoma 3A, primary open angle,\           \*231300        231300        CYP1B1        p.G61E                     1959767
                           congenital, juvenile, or adult onset                                                                               

  p.D374N                                                                                                                                     

  p.R368H                                                                                                                                     

  p.E229K                                                                                                                                     

  55                       Glycogen Storage Disease II, ACID\          232300          232300        GAA           c.2560C\>T                 ClinVar
                           ALPHA-GLUCOSIDASE DEFICIENCY                                                                                       

  c.2105G\>C;                                                                                                                                 

  56                       Griscelli syndrome, type 2                  607624          607624        RAB27A        Novel mutation             NA

  57                       Hemolytic uremic syndrome, atypical,\       612923          612923        CFI           c.1332A\>G                 CentoMD
                           susceptibility to, 3                                                                                               

  58                       Hermansky-Pudlak syndrome 2                 608233          608233        AP3B1         c.12_13delTA               16537806\
                                                                                                                                              8042664

  59                       Hyperexplexia                               \*149400        149400        GLRA1         c.593G\>C                  22264702

  60                       Hemophagocytic lymphohistiocytosis,\        \*603553        603553        PRF1          c.265C\>A                  17674359
                           familial, 2                                                                                                        

  c\. 50delT                                                                                                                                  

  c.265\>A                                                                                                                                    

  .c. 674G\>C                                                                                                                                 

  c.Del12bP                                                                                                                                   

  c.1122G\>A/\                                                                                                                                
  Del12bP                                                                                                                                     

  61                       Hyperinsulinemic hypoglycemia,\             \*256450        256450        ABCC8         c.4480C\>T                 9769320;\
                           familial, 1                                                                                                        25972930

  c.96C\>A                                                                                                                                    

  c.563A\>G                                                                                                                                   

  c.119T\>G                                                                                                                                   

  3 novel mutations                                                                                                                           

  62                       Hyperinsulinemic Hypoglycemia,\             \*147670        609968        INSR          Novel mutation             NA
                           familiar, 5                                                                                                        

  63                       Hypercholesterolemia, familial              \*143890        143890        LDLR          c.272delG                  23162007;\
                                                                                                                                              24249837

  64                       Hyperlipoproteinemia, type 1D\              \*615947        615947        GPIHBP1       C.149G\>A                  22106832
                           (chylomicronemia)                                                                                                  

  65                       HYPERPHENYLALANINEM IA BH4-\                \*261630        261630        QDPR          Novel mutation             NA
                           deficient C, (HPABH4C)                                                                                             

  66                       Hyperoxaluria, primary, type 1              259900          259900        AGXT          c.33-34insC                CentoMD;\
                                                                                                                                              21612638

  67                       Homocystinuria due to MTHFR\                \*236200        236250        MTHFR         het 677C-T                 15053809
                           deficiency                                                                                                         

  68                       Hypoparathyroidism-retardation-\            241410          241410        TBCE          c.155-166del12bp           19491227
                           dysmorphism syndrome (Sanhad-\                                                                                     
                           Sakati S)                                                                                                          

  69                       Hypophosphatasia, childhood                 241510          241510        ALPL          c\. 98C\>T                 25023282

  70                       Huntington Disease                          143100          143100        HTT           41-54 repeats              25689972

  71                       HUNTINTON-LIKE DISEASE                      \*605613        NIL           HIP1R         Novel mutation             NA

  72                       Ichthyosis, congenital, autosomal\          \*242300        242300        TGM1          c.278G\>A                  23689228
                           recessive 1                                                                                                        

  c.396A\>H                                                                                                                                   

  73                       Insensivity to pain, congenital, with\      256800          256800        NTRK1         Novel mutation             NA
                           anhydrosis (HSAN IV)                                                                                               

  74                       Isovaleric acidemia                         \*243500        243500        IVD           p.F382fs;                  22960500

  p.R392H;                                                                                                                                    

  p.R395Q;                                                                                                                                    

  p.E408K                                                                                                                                     

  75                       Jouber Syndrome 1 (JBTS1)                   \*213300        213300        INPPSE        c.1546C\>T in exon 7       19668216

  76                       Joubert syndrome 5                          \*610142        610188        CEP 290       c.21G\>T exone1            19764032

  77                       Kindler Syndrome (poikiloderma)             \*173650        173650        KIND1         R271X                      12789646

  78                       Leprechaunism                               147670          246200        INSR          Single nucleotide del\     OMIM:\
                                                                                                                   in exon 10                 147670.0028

  79                       Leukodystrophy, hypomyelinating, 2\         \*608803        608804        GJC2          c.-20+1G\>C                23143715
                           (Pelizaeus-Merzbacher-Like Disease 1)                                                                              

  80                       LCHAD deficiency                            600980          609016        HADHA         Novel mutation             NA

  C                        Lipodystrophy, congenital\                  \*613327        613327        PTRF-Cavin    c.160delG                  20300641
                           generalized, type 4                                                                                                

  82                       Lipodystrophy, congenital\                  608594          608594        AGPAT2        Homozygosity\              11916958
                           generalized, type 1 (BSCL1)                                                             D9S1818-DS1826             

  83                       Lipodystrophy, congenital\                  606158          269700        SEIPIN        Homozygocity 1883-\        12116229,
                           generalized, type 2 (BSCL2)                                                             4136                       

  84                       Lipodystrophy, familial partial, 2          150330          151660        LAMIN A\\C    Homozygosity 3757          12116229

  85                       Limb Girdle muscular dystrophy\             254130          254130        DYSF          C :526C\>T                 10469840
                           2B;LGMD2B (Miyoshi myopathy)                                                                                       

  86                       Lissencephaly LIS 4A                        300121          300121        DCX           exon 5:                    11175293

  87                       Loeys-Dietz syndrome, type 1                609192          609192        TGFBR1 or 2   Positive linkage           16928994

  88                       Long QT syndrome 1(LQT1)                    192500          192500        KCNQ1         1388G\>C                   15159330

  89                       MODY type II), Glucokinase related          \*125851        125891        GCK           c.757G\>T ;                24993573

  c\. 292C\>T;                                                                                                                                

  90                       Mental retardation, autosomal\              \*615817        615817        KIAA1033      c.3056C-G\                 2149877
                           recessive 43 (MRT 43)                                                                   transversion in exon 29    

  91                       Mental Retardation, autosomal\              \*602810        602810        HIST 3H3      c\. R130C                  21937992
                           recessive                                                                                                          

  92                       Mental Retardation Autosomal\               \*NA            NA            DEAF1         c.997+4A\>C                26048982
                           Recessive, epilepsy, autism                                                                                        

  93                       Meckel Gruber syndrome (MKS 3)              \*607361        607361        TMEM67        c\. 383-384AC del          16415887

  94                       Microcephaly with simplified gyral\         \*603807        603807        NA            Excluded known loci        17975804
                           pattern                                                                                                            

  95                       Microcephaly 3, primary, autosomal\         604804          604804        CDK5RAP2      c\. E234X                  22887808
                           recessive                                                                                                          

  96                       Microcephaly 5, primary, autosomal\         608716          608716        ASPM          c.9153_9154 del ins A      15045028
                           recessive                                                                                                          

  97                       Microcephaly and hypomielination            \*Omim 179035   NA            PYCR2         c.355C\>T                  25865492

  c.751C\>T                                                                                                                                   

  98                       Microcephalic osteodysplastic\              \*210720        210720        PCNT          Maps to 21q22.3            18174396
                           primordial dwarfism, type II                                                                                       

  99                       Mucolipidosis IV                            252650          252650        MCOLN1        c.1207C\>T                 15523648;\
                                                                                                                                              11030752;\
                                                                                                                                              16287144

  Het NM_020533:\                                                                                                                             
  c.1208G\>T.                                                                                                                                 

  100                      Mucopolysaccharidosis type IVB\             253010          252010        GLB1          c.1420G\>C                 CentoMD
                           (Morquio)                                                                                                          

  101                      Multiple endocrine neoplasia IIA\           171400          171400        RET           c.1900T\>C                 8103403
                           (MEN2A)                                                                                                            

  102                      Menkes Disease (Kinky Hair Disease)         309400          309400        ATP7A         Novel mutation             CentoMD

  Xq21.1                                                                                                                                      

  103                      Multiple pterygium syndrome, lethal\        \*100730        253290        CHRNG         c.ARG448TER                16826520
                           type                                                                                                               

  104                      Myotonic Dystrophy 1                        605377          160900        DMPK          Expansion, \>rpts\         8036515
                                                                                                                   1allele                    

  105                      Nephrotic syndrome, type 1                  \*256300        25630         NPHS1         (121delCT) ;               CentoMD;\
                                                                                                                                              9660941

  c.218C\>T                                                                                                                                   

  106                      Nephrotic syndrome, type 2, steroid\        \*600995        600995        NPHS2         c.467Dup/c.709G\>;         CentoMD;\
                           resistant (NPHS2; SRN1)                                                                                            15817495

  c.709G\>C                                                                                                                                   

  c.779T\>A;                                                                                                                                  

  107                      Noonan syndrome 1 (NS1)                     163150          163150        PTPN11        c.218C\>T                  12161469

  108                      Niemann-Pick disease, type C1\              \*257220        257220        NPC1          c.3362T\>G                 Cento MD
                           (NPC1)                                                                                                             

  109                      Osteogenesis imperfecta, type VIII          610915          610915        LEPRE1        c.2075-1G\>A               24498616;\
                                                                                                                                              LOVD

  c.1170+9G\>A                                                                                                                                

  110                      Osteogenesis imperfecta, type VI            613982          613982        SERPINF1      c.-9+2dup                  23054245

  111                      Osteopetrosis, infantilile malignant        \*259700        259700        TCIRG1        c.-XY\_-YZdel              23685543

  112                      Orofaciodigital syndrome V                  \*174300        174300        DDX59         c.1600G\>A                 23972372

  113                      Paroxysmal nonkinesigenic dyskinesia\       \*118800        118800        MR-1 gene     c.20C\>T : A7V ;           16632198
                           (PNKD1)                                                                                                            

  c.26C\>T : A9V)                                                                                                                             

  114                      Peroxisome biogenesis disorder 1A\          602136          214100        PEX-1         c.1927_1928dupA;. c.\      PMCID:\
                           (Zellweger)                                                                             2088A\>G                   2649967;\
                                                                                                                                              25407003

  115                      Pelger-Huet anomaly                         \*169400        169400        LBR           del 6 BP in splice site\   21326950
                                                                                                                   intron 12                  

  116                      Pheochromosytoma/paraganglioma 4            115310          115310        SDHB          c.771dup.A;                25034258;\
                                                                                                                                              15328326

  c.574T\>C;                                                                                                                                  

  c.859G\>A;                                                                                                                                  

  117                      Pituitary hormone deficiency,\              \*221750        221750        LHX3          3,088-bp deletion          18407919
                           combined, 3                                                                                                        

  118                      Pontocerebellar Hypoplasia type III         \*608027        608027        PCLO          nonsense mutation of\      25832664
                                                                                                                   *PCLO* ( *piccolo*) gene   

  119                      Polycystic Kidney and Hepatic\              263200          263200        FCYT          c.107C\>T                  11919560
                           Disease 1                                                                                                          

  120                      Polycystic liver disease                    608648          608648        SEC63         Del in promoter\           24886261\
                                                                                                                   region                     25165181

  121                      Rabson-Mendenhall syndrome                  262190          262190        INSR          c.671_685dup               CentoMD;\
                                                                                                                                              22824672

  122                      Rajab Syndrome                              \*613658        613658        NA            linkage D2S351/\           19161147
                                                                                                                   D2S2390                    

  123                      Renal tubular acidosis, distal, AR, with\   \*611590        611590        SLC4A1        A858D;                     22126643
                           hemolitic anaemia                                                                                                  

  A858D/N                                                                                                                                     

  124                      Retinitis pigmentosa-12, autosomal\         \*604210        600105        RABS 1        7 mutations                24512366
                           recessive                                                                                                          

  125                      Retinitis pigmentosa 37                     \*604485        268100        NR2E3         p.D406G                    24891813

  126                      Rett Syndrome                               312750          312750        MECP2         c.880C\>T                  ClinVar

  127                      Robinow syndrome, autosomal\                \*268310        268310        ROR 2         c.1504C\>T                 10932186;\
                           recessive                                                                                                          19640924

  c.1324C\>T                                                                                                                                  

  128                      Severe combined immunodeficiency,\          179615          601457        RAG1          c.1187G\>A                 ClinVar
                           B cell-negative                                                                                                    

  129                      Spinal Muscular Atrophy (SMN1)              253300          253300        SMN1          del exons 5, 6, 8 ;        15000810;\
                                                                                                                                              17940251

  Del 5q13.2 in exon 7                                                                                                                        

  130                      Spastic paraplegia 18, autosomal\           \*611225        611225        ERLIN 2       (D8S1820 and\              16636240
                           recessive (IDMDC)                                                                       D8S532)                    

  131                      Spastic paraplegia 20, SPG20; (Troyer\      \*275900        275900        SPG 20        c.123X                     20437587
                           Syndrome)                                                                                                          

  132                      Spastic paraplegia 35, autosomal\           612319          612319        FA2H          c.235A\>C                  20104589
                           recessive; (FAHN); Leukodystrophy,\                                                                                
                           dysmyelinating, and spastic\                                                                                       
                           paraparesis                                                                                                        

  133                      Spastic paraplegia 54, autosomal\           \*615033        615003.0005   DDHD2         1546C-T transition         23176823
                           recessive                                                                                                          

  134                      Spastic paraplegia, ataxia, and\            \*607565        607565        GRID2         Novel mutation             NA
                           mental retardation                                                                                                 

  135                      Split-hand/foot malformation with long\     \*612576        612576        BHLHA9        microduplications          22147889
                           bone deficiency 3                                                                                                  

  136                      Spondylometaepiphyseal dysplasia,\          \*271665        271665        DDR2          c.2468_2469del CT          24725993
                           short limb-hand type (SMED-SL)                                                                                     

  137                      Spondyloepiphyseal dysplasia Omani\         \*143095        1439095       CHST3         c\. 911G\>A                15215498
                           type with congenital joint dislocations                                                                            

  138                      Spondylocostal dysostosis 2,\               605915          608681        MESP2;        c.880C\>T                  ClinVar
                           autosomal recessive                                                                                                

  139                      Spinocerebellar ataxia 7;\                  164500          164500        ATXN7;        Repeat expansion of\       ClinVar
                           Olivopontocerebellar atrophy III;\                                                      ATXN7 gene                 
                           ADCA type II                                                                                                       

  140                      Schwartz-Jampel syndrome, type 1            \*255800        255800        HSPG-2        IVS64DS, A-G, +4;\         11101850
                                                                                                                   c.1532C\>T                 

  141                      Stuve-Wiedemann syndrome/\                  601559          601559        LIFR          c.653_654insT              14740318
                           Schwartz-Jampel type 2 syndrome                                                                                    

  c.643del T;                                                                                                                                 

  142                      Systemic Lupus Erythematosus (SLE),\        \*125505        152700        DNASE1L3      G38OR ;                    22019780
                           susceptibility.                                                                                                    

  143                      Thanatophoric Dysplasia type 1              \*187600        187600        FGFR-3        R248C                      12633765

  c.4406A\>G                                                                                                                                  

  144                      Three-M syndrome 1                          \*273750        273750        CUL           c2434C\>T                  19225462

  690 ins C                19877176                                                                                                           

  145                      Three M Syndrome 2                          \*610991        612921        OBCL1         844ins68                   19877176

  146                      Thrombosis, hyperhomocysteinemic            \*236200        236200        CBS           c.807C\>A;                 16432849

  147                      Thyroid hormone resistance,\                190160          274300        TRB2          del in exon10              1991834
                           autosomal recessive                                                                                                

  Novel mutation           NA                                                                                                                 

  148                      von Hippel-Lindau syndrome (VHL)            \*193300        193300        VHL           Novel mutation             NA
  --------------------------------------------------------------------------------------------------------------------------------------------------------------

The disorders are listed in alphabetical order along with the mutations detected in Omani patients. Novel genes and/or mutations identified for the first time in Omani nationals are marked by an asterisk (\*). Unpublished mutation data referred as "Novel mutations" would be updated following publication, currently source stated as "NA".

###### Mutations associated with hemoglobin disorders in the Omani population.

  ------------------------------------------------------------------------------------------------------
  Disease                                         OMIM       Gene/Locus   Nucleotide change   PMID
  ----------------------------------------------- ---------- ------------ ------------------- ----------
  Sickle cell anemia/\                            603903     HBB          c.19G\>A            25677748
  Hemoglobin variants                                                                         

  c.20A\>T                                        81926                                       

  c.92G\>C                                        25677748                                    

  c.97C\>G                                        1517102                                     

  c.79G\>A                                        25677748                                    

  c.176C\>A                                       25677748                                    

  c.176C\>G                                       25677748                                    

  c.364G\>A                                       25677748                                    

  c.364G\>C                                       25677748                                    

  c.389C\>T                                       25677748                                    

  Beta Thalassemia                                613985     HBB          c.-151C\>T          25677748

  c.-138C\>A                                      25677748                                    

  c.-121C\>T\*                                    21801233                                    

  c.-102G\>T\*                                    25826385                                    

  c.17_18delCT                                    25677748                                    

  c.27_28insG                                     25677748                                    

  c.32C\>T                                        25677748                                    

  c.47G\>A                                        20353347                                    

  c.51delC                                        20353347                                    

  c.90C\>T                                        25677748                                    

  c.92G\>A                                        25677748                                    

  c.92+1G\>A                                      25677748                                    

  c.92+5G\>C                                      25677748                                    

  c.92+6T\>C                                      25677748                                    

  c.93-22_95del                                   25677748                                    

  c.93-21G\>A                                     25677748                                    

  c.93-3T\>G                                      25677748                                    

  c.118C\>T                                       25677748                                    

  c.126_129delCTTT                                20353347                                    

  c.135delC                                       25677748                                    

  c.315+1G\>A                                     25677748                                    

  c.316-2A\>G                                     25677748                                    

  c.\*108\_\*112delAATAA                          25677748                                    

  Alpha Thalassemia                               604131     HBA1/HBA2    c.24G\>C            25370869

  c.38C\>A                                        25370869                                    

  c.43T\>C                                        25370869                                    

  c.55G\>C                                        24165563                                    

  c.56G\>A                                        25370869                                    

  c.56delG                                        25370869                                    

  c.64G\>C;                                       25370869                                    

  c.71A\>T                                        5675637                                     

  c.95+2_c.95+6delTGAGG                           25370869                                    

  c.118_120delACC                                 25370869                                    

  c.181A\>G                                       25370869                                    

  c.264C\>G                                       25826385                                    

  c.283_300+3dup\*                                25370869                                    

  c.326C\>A                                       16840225                                    

  c.427T\>C                                       25370869                                    

  c.\*92A\>G                                      25370869                                    

  c.\*94A\>G                                      25370869                                    

  Hybrid 3.7 -5 (C\>T)\*                          25370869                                    

  Hybrid 3.7 +46 (C\>A)\*                         25370869                                    

  \- -(MED-I); deletion of \~17.5 kb including\   25370869                                    
  both alpha-globin genes                                                                     

  3.7 kb deletion                                 25370869                                    

  4.2 kb deletion                                 25370869                                    

  Delta Thalassemia                               142000     HBD          c.-118C\>T          24985928

  c.14C\>T                                        24985928                                    

  c.49G\>C                                        24985928                                    

  c.68C\>A                                        6058951                                     

  c.82G\>T                                        24985928                                    

  c.93-1G\>C                                      24985928                                    

  c.295G\>A                                       2477064                                     

  c.301C\>T                                       24985928                                    

  c.333-334insGT\*                                24985928                                    

  c.350G\>A                                       24985928                                    

  c.410G\>A                                       24985938                                    

  c.422C\>T                                       17145605                                    

  c.427G\>C\*                                     25043855                                    

  c.443G\>T\*                                     24985928                                    
  ------------------------------------------------------------------------------------------------------

The different mutations reported by the National Genetic Center in patients with Hemoglobinopathies in Oman. Novel mutations are indicated by an asterisk (\*) indicated to the left side of the mutation. Mutations are listed in ascending order based on nucleotide position.

For the majority (85%) of rare disorders presented in [Table 2](#T2){ref-type="table"}, data was derived from publications. The original mutations identified for the first time in Omani population constitute more than half of rare disease data presented in [Table 2](#T2){ref-type="table"}.

Discussion
==========

Soon after the completion of the Human Genome Project in 2003, it was clear that the genetic data collected until then presented only a glimpse of the complexity of the human genome and the significance of genetic variants in human disease. Since then, genetic researchers have unearthed innumerable variants that are not only individual-specific; but also ethnicity-, population- and country-specific. Human genetic variation databases have significant implications for both diagnostic and predictive medicine. Often, the pathogenicity of rare mutations is primarily assessed through multiple reports of occurrence in diseased patients that are documented and routinely updated in mutation databases. Given the fact that gene mutations and their frequencies in many Mendelian disorders differ widely between different ethnic groups, even within a country, national databases are highly valuable resources for studies on disease-gene associations, population diversity and genetic history ^[@ref-10]^.

The catalog of Omani mutations presented here will therefore represent a valuable resource that may guide mutation analysis in Omanis suspected of having genetic disease. Unique circumstances in Oman with government-funded comprehensive healthcare throughout the country, and the national coverage for clinical genetics has made the present study possible. Future efforts will be required to extend this database to cover the full spectrum of mutations and population specific variants.

The disease-associated mutation data presented ( [Table 1](#T1){ref-type="table"}, [Table 2](#T2){ref-type="table"}, [Table 3](#T3){ref-type="table"}) show a considerable proportion of novel disease genes as well as novel genetic variants within the Omani population. This was expected due to the presence of inbred and geographically isolated communities, the practice of consanguineous marriages, all of which have tended to skew the allelic spectrum toward rare and private variants within the Omani population. In addition to this, the list of genetic variants also reveals known mutations that were previously reported in certain non-Omani populations, thereby reflecting the historic genetic admixture that occurred in Oman, along the trade routes of a once powerful Omani empire and its foreign colonies. Many of the mutations reported are unique to the Omani population, suggesting a founder effect.

The interest in genetic testing is growing among physicians aiming to provide better medical care and genetic disease prevention. The data collected largely represent mutations of rare autosomal recessively inherited disorders in Oman. The mutation data in [Table 2](#T2){ref-type="table"} can be searched by OMIM number, or by disease name. The names of diseases in [Table 2](#T2){ref-type="table"} were chosen as described in OMIM in "Phenotype-Gene Relationships" table as "Phenotype" in order to ease finding specific genetic disorders by name.

The number of collected mutations among different disease groups ( [Table 1](#T1){ref-type="table"}) reflect the frequency of disorders in the Omani population, the burden caused by genetic diseases ^[@ref-4]^, and the interests of individual clinicians in genetic testing.

The knowledge of the genetics of Hemoglobin disorders is among the best in Oman due to national preventive programs and research starting from the 1990s. It is not surprising that around a third of all mutations known in Omani population to date are in four genes causing Hemoglobin disorders ( [Table 1](#T1){ref-type="table"}, [Table 3](#T3){ref-type="table"}). The birth prevalence of infants with a hemoglobin disorder was recorded as 3.5--4.7/1,000 ^[@ref-7],\ [@ref-11]^. The frequency of hemoglobin disorders in Oman is among the highest in the world, and may reflect natural selection due to advantage for survival, in the heterozygous state, against malaria. Around 10% of Omani nationals are carriers of the allele for sickle cell anemia, 2--3% carry an allele for Beta-thalassemia and 45% are carriers of an alpha-thalassemia allele ^[@ref-12]--\ [@ref-15]^.

Genetic disorders causing disabilities and handicap are of great concern. These are different groups of rare disorders leading to intellectual disability or physical handicap requiring detailed clinical classification, genetic testing, research and preventive measures. The high prevalence of birth defects and genetic conditions in Omani communities causes social, psychological and financial difficulties ^[@ref-4]^. The development and use of national mutation data is of importance to Omani medical care because it not only allows the genetic burden of disease to be quantified, but also provides diagnosticians and researchers access to an up-to-date resource that will assist them in their daily clinical practice and biomedical research ^[@ref-9]^. National databases for genetic variants are also significant from the perspective of preventive healthcare. There is a significant correlation between the occurrence of rare genetic variants associated with Mendelian disease and the burden of morbidity from complex diseases within a population. Heterozygous carriers for recessive disease genes do not manifest the recessive disease but may be at risk of developing complex trait conditions with some similarity in phenotype. For example, heterozygote carriers of mutations in the ataxia telangiectasia gene locus are reportedly susceptible to breast cancer ^[@ref-16]^, and heterozygote carriers of mutations in the glucocerebrosidase ( *GBA*) gene causing Gaucher disease are at an increased risk for Parkinson disease ^[@ref-17],\ [@ref-18]^. Hence, the collection of genetic variant data in national databases will contribute significantly to the prevention of genetic diseases in the population and might greatly impact the management of complex trait diseases in the future. Genetic scientists and international consortiums studying human genetic variation are increasingly interested in dissecting the interplay between genetic makeup and environmental influences on the pattern of diseases worldwide. Current research is expected to create a foundation for the national data online for the benefit of Oman Healthcare.

Data availability
=================

This article was prepared to introduce the first Omani genetic variation database. This data is available online at <HTTP://ogvd.net>; raw datasets are not available for Royal Hospital laboratory and clinical data, as the registry contains confidential information that could not be deidentified.
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Its useful to have region/country specific databases that present a better representation of the prevalence and incidence of region specific diseases and health issues. Putting such data in context of whats known globally shall help in better interpreting whats peculiar to local population and possibly raise some interesting questions on why so? For example, is it the genetic structure or something in the environment?

Some specific comments follow: Authors mention existence of tribal structures, consanguineous marriages etc in Omani society. Is it possible to delineate the effects of these factors on the reported mutations? For example, is this reported in the papers that the authors have collated data from and have the authors noted this aspect in their database?How does the mutation data reported here compare with mutation patterns or frequency seen in other populations? Do the authors provide information on this or link out to other similar resources from other countries? If a physician in Oman is looking up some mutation from this database and wants to know if this is something specific to Oman or is a more general mutation found in other populations too, would this information appear automatically in the database; or could they perform a manual search of the database?Do the authors want to comment about any data privacy issues that maybe associated with such a database, if any and to what extent?Are there any attributes on quality of data in the database? perhaps based on the technique used in the original paper or some other measure some quality metric can be assigned to the mutation information recorded in the database?It would be helpful if authors were able to illustrate out a case or two on how they expect a doctor in Oman to be able to use this database in a real clinical setting; to illustrate the usefulness of the database from a simple collection of data to something that can be used on a more regular basis by doctors in clinical setting.
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The paper is well-written and though it does not present any new findings, it can be used as a reference database for Omani mutations.There are a few suggestions for the authors:a. Standard HGVS nomenclature should be followed for all the mutations and the authors should preferably stick to one format i.e. either DNA or protein notation. There is no uniformity in the present nomenclature followed in Table 2.b. Number of patients in whom each mutation was found, should be indicated -- this would give an idea about any preponderance of specific mutations in this population.c. Functional validation studies, if available, or at least the mutation prediction scores should be mentioned for the novel sequence variants identified, which will help create a comprehensive database of new likely-pathogenic variants. Again, if the number of patients in whom each of these novel variants were identified is mentioned, we will get an idea as to whether these novel variants were present in more than one case and we can get further proof of the pathogenicity of these mutations.d. It would also be interesting to see if there is any ethnic group-wise preponderance of genetic diseases or mutations in the various subsets/ tribes/ regional groups that constitute the Omani population.
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